Unfractionated heparin during elective PCI

Fixed dose or weight adjusted?

Ananth Kidambi, Gnanamoorthy Mayurathan, Girish Viswanathan, Clyde B. Schechter, Azfar G. Zaman

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Introduction: To assess two different dosing strategies of unfractionated heparin (UFH) during elective percutaneous coronary intervention (PCI). Aims: The optimal dose of heparin during elective PCI in patients with stable angina is unknown. Existing guidelines are based on limited data. We interrogated data from the PCI database. Patients with stable angina undergoing planned transradial PCI for uncomplicated single lesions were included. The main endpoint was troponin I release. We compared a fixed heparin dose (3000 U) UFH to a weight-adjusted dose. Results: Of 698 patients 244 (35.0%) received fixed dose (3000 U) and 454 (65.0%) 70 U/kg weight-adjusted UFH. There was no significant difference in median troponin between the fixed dose and the weight-adjusted groups; 0.17 ng/mL versus 0.14; P= 0.21. The proportion of troponin positive patients was similar in both groups (61.9% in the fixed dose group vs. 58.1%; P= 0.37). There were no deaths or major ischemic events during hospitalization. There was no bleeding requiring transfusion or delaying hospital discharge. Conclusion: In conclusion, this retrospective observational study of elective transradial PCI demonstrated that a reduced, fixed dose of periprocedural heparin was associated with similar postprocedural troponin levels when compared to a standard weight-adjusted regime. Our study further questions the optimal dose of heparin required during elective PCI and suggests a need for further trials.

Original languageEnglish (US)
Pages (from-to)1-4
Number of pages4
JournalCardiovascular Therapeutics
Volume30
Issue number1
DOIs
StatePublished - Feb 2012

Fingerprint

Percutaneous Coronary Intervention
Heparin
Weights and Measures
Troponin
Stable Angina
Troponin I
Observational Studies
Hospitalization
Retrospective Studies
Databases
Guidelines
Hemorrhage

Keywords

  • Coronary artery disease
  • Heparin
  • Percutaneous coronary intervention
  • Troponin

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pharmacology (medical)
  • Pharmacology

Cite this

Unfractionated heparin during elective PCI : Fixed dose or weight adjusted? / Kidambi, Ananth; Mayurathan, Gnanamoorthy; Viswanathan, Girish; Schechter, Clyde B.; Zaman, Azfar G.

In: Cardiovascular Therapeutics, Vol. 30, No. 1, 02.2012, p. 1-4.

Research output: Contribution to journalArticle

Kidambi, Ananth ; Mayurathan, Gnanamoorthy ; Viswanathan, Girish ; Schechter, Clyde B. ; Zaman, Azfar G. / Unfractionated heparin during elective PCI : Fixed dose or weight adjusted?. In: Cardiovascular Therapeutics. 2012 ; Vol. 30, No. 1. pp. 1-4.
@article{fcaa97756dcb430690931e4d49f9e737,
title = "Unfractionated heparin during elective PCI: Fixed dose or weight adjusted?",
abstract = "Introduction: To assess two different dosing strategies of unfractionated heparin (UFH) during elective percutaneous coronary intervention (PCI). Aims: The optimal dose of heparin during elective PCI in patients with stable angina is unknown. Existing guidelines are based on limited data. We interrogated data from the PCI database. Patients with stable angina undergoing planned transradial PCI for uncomplicated single lesions were included. The main endpoint was troponin I release. We compared a fixed heparin dose (3000 U) UFH to a weight-adjusted dose. Results: Of 698 patients 244 (35.0{\%}) received fixed dose (3000 U) and 454 (65.0{\%}) 70 U/kg weight-adjusted UFH. There was no significant difference in median troponin between the fixed dose and the weight-adjusted groups; 0.17 ng/mL versus 0.14; P= 0.21. The proportion of troponin positive patients was similar in both groups (61.9{\%} in the fixed dose group vs. 58.1{\%}; P= 0.37). There were no deaths or major ischemic events during hospitalization. There was no bleeding requiring transfusion or delaying hospital discharge. Conclusion: In conclusion, this retrospective observational study of elective transradial PCI demonstrated that a reduced, fixed dose of periprocedural heparin was associated with similar postprocedural troponin levels when compared to a standard weight-adjusted regime. Our study further questions the optimal dose of heparin required during elective PCI and suggests a need for further trials.",
keywords = "Coronary artery disease, Heparin, Percutaneous coronary intervention, Troponin",
author = "Ananth Kidambi and Gnanamoorthy Mayurathan and Girish Viswanathan and Schechter, {Clyde B.} and Zaman, {Azfar G.}",
year = "2012",
month = "2",
doi = "10.1111/j.1755-5922.2010.00231.x",
language = "English (US)",
volume = "30",
pages = "1--4",
journal = "Cardiovascular Therapeutics",
issn = "1755-5914",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Unfractionated heparin during elective PCI

T2 - Fixed dose or weight adjusted?

AU - Kidambi, Ananth

AU - Mayurathan, Gnanamoorthy

AU - Viswanathan, Girish

AU - Schechter, Clyde B.

AU - Zaman, Azfar G.

PY - 2012/2

Y1 - 2012/2

N2 - Introduction: To assess two different dosing strategies of unfractionated heparin (UFH) during elective percutaneous coronary intervention (PCI). Aims: The optimal dose of heparin during elective PCI in patients with stable angina is unknown. Existing guidelines are based on limited data. We interrogated data from the PCI database. Patients with stable angina undergoing planned transradial PCI for uncomplicated single lesions were included. The main endpoint was troponin I release. We compared a fixed heparin dose (3000 U) UFH to a weight-adjusted dose. Results: Of 698 patients 244 (35.0%) received fixed dose (3000 U) and 454 (65.0%) 70 U/kg weight-adjusted UFH. There was no significant difference in median troponin between the fixed dose and the weight-adjusted groups; 0.17 ng/mL versus 0.14; P= 0.21. The proportion of troponin positive patients was similar in both groups (61.9% in the fixed dose group vs. 58.1%; P= 0.37). There were no deaths or major ischemic events during hospitalization. There was no bleeding requiring transfusion or delaying hospital discharge. Conclusion: In conclusion, this retrospective observational study of elective transradial PCI demonstrated that a reduced, fixed dose of periprocedural heparin was associated with similar postprocedural troponin levels when compared to a standard weight-adjusted regime. Our study further questions the optimal dose of heparin required during elective PCI and suggests a need for further trials.

AB - Introduction: To assess two different dosing strategies of unfractionated heparin (UFH) during elective percutaneous coronary intervention (PCI). Aims: The optimal dose of heparin during elective PCI in patients with stable angina is unknown. Existing guidelines are based on limited data. We interrogated data from the PCI database. Patients with stable angina undergoing planned transradial PCI for uncomplicated single lesions were included. The main endpoint was troponin I release. We compared a fixed heparin dose (3000 U) UFH to a weight-adjusted dose. Results: Of 698 patients 244 (35.0%) received fixed dose (3000 U) and 454 (65.0%) 70 U/kg weight-adjusted UFH. There was no significant difference in median troponin between the fixed dose and the weight-adjusted groups; 0.17 ng/mL versus 0.14; P= 0.21. The proportion of troponin positive patients was similar in both groups (61.9% in the fixed dose group vs. 58.1%; P= 0.37). There were no deaths or major ischemic events during hospitalization. There was no bleeding requiring transfusion or delaying hospital discharge. Conclusion: In conclusion, this retrospective observational study of elective transradial PCI demonstrated that a reduced, fixed dose of periprocedural heparin was associated with similar postprocedural troponin levels when compared to a standard weight-adjusted regime. Our study further questions the optimal dose of heparin required during elective PCI and suggests a need for further trials.

KW - Coronary artery disease

KW - Heparin

KW - Percutaneous coronary intervention

KW - Troponin

UR - http://www.scopus.com/inward/record.url?scp=84856249899&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856249899&partnerID=8YFLogxK

U2 - 10.1111/j.1755-5922.2010.00231.x

DO - 10.1111/j.1755-5922.2010.00231.x

M3 - Article

VL - 30

SP - 1

EP - 4

JO - Cardiovascular Therapeutics

JF - Cardiovascular Therapeutics

SN - 1755-5914

IS - 1

ER -